Search research articles
Contact Us
Filters
Showing results (41-50 of 214) with videos related to
Page
of 22
Sort By:
Cancer
|
February 6, 2009
Mechanisms of constitutive activation of Janus kinase 2-V617F revealed at the atomic level through molecular dynamics simulations
Tai-Sung Lee, Wanlong Ma, Xi Zhang, et al.
Leukemia Research
|
March 7, 2003
Pilot study of recombinant human soluble tumor necrosis factor (TNF) receptor (p75) fusion protein (TNFR:Fc; Enbrel) in patients with refractory multiple myeloma: increase in plasma TNF alpha levels during treatment
Apostolia Maria Tsimberidou, Tracey Waddelow, Hagop M Kantarjian, et al.
Leukemia Research
|
October 19, 2010
Ubiquitin-proteasome system profiling in acute leukemias and its clinical relevance
Wanlong Ma, Hagop Kantarjian, Xi Zhang, et al.
Leukemia Research
|
October 12, 2004
Alemtuzumab: validation of a sensitive and simple enzyme-linked immunosorbent assay
Iman Jilani, Michael Keating, Francis J Giles, et al.
Acta Haematologica
|
April 1, 2009
BCR-ABL truncation due to premature translation termination as a mechanism of resistance to kinase inhibitors
Wanlong Ma, Hagop Kantarjian, Chen-Hsiung Yeh, et al.
Leukemia & Lymphoma
|
October 11, 2007
A potential role for HSP90 inhibitors in the treatment of JAK2 mutant-positive diseases as demonstrated using quantitative flow cytometry
Joanne Bareng, Iman Jilani, Mercedes Gorre, et al.
Cancer
|
September 5, 2002
Prognostic value of plasma interleukin-6 levels in patients with chronic lymphocytic leukemia
Raymond Lai, Susan O'Brien, Taghi Maushouri, et al.
Plos One
|
August 23, 2011
Effects of clinically relevant MPL mutations in the transmembrane domain revealed at the atomic level through computational modeling
Tai-Sung Lee, Hagop Kantarjian, Wanlong Ma, et al.
Cancer
|
March 15, 2008
Molecular basis explanation for imatinib resistance of BCR-ABL due to T315I and P-loop mutations from molecular dynamics simulations
Tai-Sung Lee, Steven J Potts, Hagop Kantarjian, et al.
Journal of Clinical Pathology
|
October 3, 2018
A real-world, comparative study of FDA-approved diagnostic assays PD-L1 IHC 28-8 and 22C3 in lung cancer and other malignancies
Cory Batenchuk, Maher Albitar, Kim Zerba, et al.
Page
of 22
Search research articles
Search
Showing results (41-50 of 214) with videos related to
Sort By:
Page
of 22
Cancer
|
February 6, 2009
Mechanisms of constitutive activation of Janus kinase 2-V617F revealed at the atomic level through molecular dynamics simulations
Tai-Sung Lee, Wanlong Ma, Xi Zhang, et al.
Leukemia Research
|
March 7, 2003
Pilot study of recombinant human soluble tumor necrosis factor (TNF) receptor (p75) fusion protein (TNFR:Fc; Enbrel) in patients with refractory multiple myeloma: increase in plasma TNF alpha levels during treatment
Apostolia Maria Tsimberidou, Tracey Waddelow, Hagop M Kantarjian, et al.
Leukemia Research
|
October 19, 2010
Ubiquitin-proteasome system profiling in acute leukemias and its clinical relevance
Wanlong Ma, Hagop Kantarjian, Xi Zhang, et al.
Leukemia Research
|
October 12, 2004
Alemtuzumab: validation of a sensitive and simple enzyme-linked immunosorbent assay
Iman Jilani, Michael Keating, Francis J Giles, et al.
Acta Haematologica
|
April 1, 2009
BCR-ABL truncation due to premature translation termination as a mechanism of resistance to kinase inhibitors
Wanlong Ma, Hagop Kantarjian, Chen-Hsiung Yeh, et al.
Leukemia & Lymphoma
|
October 11, 2007
A potential role for HSP90 inhibitors in the treatment of JAK2 mutant-positive diseases as demonstrated using quantitative flow cytometry
Joanne Bareng, Iman Jilani, Mercedes Gorre, et al.
Cancer
|
September 5, 2002
Prognostic value of plasma interleukin-6 levels in patients with chronic lymphocytic leukemia
Raymond Lai, Susan O'Brien, Taghi Maushouri, et al.
Plos One
|
August 23, 2011
Effects of clinically relevant MPL mutations in the transmembrane domain revealed at the atomic level through computational modeling
Tai-Sung Lee, Hagop Kantarjian, Wanlong Ma, et al.
Cancer
|
March 15, 2008
Molecular basis explanation for imatinib resistance of BCR-ABL due to T315I and P-loop mutations from molecular dynamics simulations
Tai-Sung Lee, Steven J Potts, Hagop Kantarjian, et al.
Journal of Clinical Pathology
|
October 3, 2018
A real-world, comparative study of FDA-approved diagnostic assays PD-L1 IHC 28-8 and 22C3 in lung cancer and other malignancies
Cory Batenchuk, Maher Albitar, Kim Zerba, et al.
Page
of 22